garenoxacin has been researched along with Bites in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Citron, DM; Fernandez, HT; Goldstein, EJ; Merriam, CV; Tyrrell, KL; Warren, YA | 1 |
| Citron, DM; Fernandez, H; Goldstein, EJ; Merriam, CV; Tyrrell, KL; Warren, YA | 1 |
2 other study(ies) available for garenoxacin and Bites
| Article | Year |
|---|---|
In vitro activities of garenoxacin (BMS-284756) against 170 clinical isolates of nine Pasteurella species.
Topics: Anti-Infective Agents; Bites and Stings; Culture Media; Drug Resistance, Bacterial; Fluoroquinolones; Humans; Indoles; Microbial Sensitivity Tests; Pasteurella; Pasteurella Infections; Quinolones; United States | 2002 |
In vitro activities of the des-fluoro(6) Quinolone BMS-284756 against aerobic and anaerobic pathogens isolated from skin and soft tissue animal and human bite wound infections.
Topics: Animals; Anti-Infective Agents; Bacteria, Aerobic; Bacteria, Anaerobic; Bites and Stings; Cats; Dogs; Fluoroquinolones; Humans; Indoles; Microbial Sensitivity Tests; Quinolones; Skin Diseases, Infectious; Soft Tissue Infections | 2002 |